BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34253424)

  • 41. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis.
    Markovic I; Goran M; Besic N; Buta M; Djurisic I; Stojiljkovic D; Zegarac M; Pupic G; Inic Z; Dzodic R
    J BUON; 2018; 23(4):1049-1054. PubMed ID: 30358210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.
    Nixon IJ; Wang LY; Ganly I; Patel SG; Morris LG; Migliacci JC; Tuttle RM; Shah JP; Shaha AR
    Br J Surg; 2016 Feb; 103(3):218-25. PubMed ID: 26511531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
    Barczyński M; Konturek A; Stopa M; Nowak W
    Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.
    Choi WR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jul; 94():106-110. PubMed ID: 31178204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.
    Moreno MA; Edeiken-Monroe BS; Siegel ER; Sherman SI; Clayman GL
    Thyroid; 2012 Apr; 22(4):347-55. PubMed ID: 22280230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Nylén C; Eriksson FB; Yang A; Aniss A; Turchini J; Learoyd D; Robinson BG; Gill AJ; Clifton-Bligh RJ; Sywak MS; Glover AR; Sidhu SB
    Am J Surg; 2021 May; 221(5):886-892. PubMed ID: 32878695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of adjuvant radioactive iodine therapy after reoperation in papillary thyroid carcinoma with cervical lymph node recurrence.
    Zhang Y; Zhu X; Fan Q; Huang Q; Tu Y; Jiang L; Zhang Z; Chen J
    Jpn J Radiol; 2023 Oct; 41(10):1148-1156. PubMed ID: 37266825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
    Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
    Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
    Macedo FI; Mittal VK
    Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncologic outcomes of robotic thyroidectomy: 5-year experience with propensity score matching.
    Tae K; Song CM; Ji YB; Sung ES; Jeong JH; Kim DS
    Surg Endosc; 2016 Nov; 30(11):4785-4792. PubMed ID: 26895921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?
    Ma T; Wang H; Liu J; Zou J; Liu S
    Front Endocrinol (Lausanne); 2021; 12():723631. PubMed ID: 34434171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological features of recurrent papillary thyroid cancer.
    Zhu J; Wang X; Zhang X; Li P; Hou H
    Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.